How the Monkeypox Vaccine Scam Mirrors the COVID Vaccine Scam: Animal Trials show Monkeypox Vaccine does NOT Stop Transmission
Just like the COVID vaccines, turns out that in the animal experiments, Jynneos did not stop monkeys getting monkeypox, but did stop them from dying. Since the current strain of monkeypox is mild, and virtually no one dies from monkeypox, this is another reason to avoid these dangerous vaccines like the plague—they won’t stop the infection! The US Government has created a fake shortage of vaccine. Well yes, of course, they always do that to fan the flames of demand. But this is a lot bigger than that. The USG already owns 16 million doses, stored frozen in Denmark, and had spent well over $1 Billion on Jynneos vaccines before Moneypox was identified in the west. Despite the Denmark factory's "fill and finish” facility being completed in 2021, and despite the USG allotting $44 million for “qualification” of that same facility in January 2019, the FDA only got around to finishing its inspection on July 27, 2022. Because of the vaccine "shortage," the existing vaccine will get a liability waiver. How sweet is that? Jynneos is licensed, and is being used for its labelled indication (prevention of Moneypox) so the manufacturer is liable for injuries. The USG might also be liable, if it steered you wrong about the safety or efficacy of the vaccine…or if it hid a study it had conducted, for example. But since we have a shortage, the USG in its benevolence and wisdom is going to dilute it and give recipients instead a 20% dose, administered intradermally instead of subcutaneously. But in order to make this kosher (kosher for whom?) the DHHS and FDA are issuing the vaccine an emergency use authorization, and we all know what that means. You can’t sue anybody even if the vaccine kills you.